How to Establish a Fertility, IVF or Reproductive-Medicine Clinic in the UAE

Clinical activity is regulated by emirate. DHA covers facilities in Dubai, DoH covers facilities in Abu Dhabi, and MoHAP sets the federal laws both sit under. Which authority governs a clinic depends on where the premises are, not where the company is incorporated.

For a fertility or IVF clinic that question has an extra layer: the facility is not only consultation rooms, but can include an embryology laboratory, storage for gametes and embryos, and a procedure theatre. These can sit inside one facility licence or be split across more than one approved party, and the health authority, not the commercial licensing office, decides the facility's class and approved scope. Ask for that classification in writing before signing a lease or ordering laboratory equipment.

The health authorities set the conditions for a facility: its classification, approved scope, premises, equipment and the licensed professionals inside it. Each authority publishes its own licensing pages and standards. Above both sits Federal Law No. 7 of 2019 Concerning Medically Assisted Reproduction, which MoHAP administers: it confines these techniques to a centre licensed for that purpose. Read the current source for the relevant emirate, and the current text of that federal law, directly, because scope and standards are the kind of detail that changes.

Four points follow. First, the procedure scope is approved, not assumed: consultation-only and full assisted-reproduction are different approved scopes, and adding a procedure or laboratory service later is a change to that scope, not an internal decision. Second, professionals are licensed individually, so a facility licence does not cover a doctor or embryologist with no personal licence; recruitment follows the facility and scope decision rather than leading it. Third, the federal law narrows who can be treated and whose gametes are used: it does not permit the technique using eggs or sperm from a donor outside the patient's own marriage, so intake and consent need to screen this out before treatment starts, not after. Fourth, patient and genetic data carries its own legal layer. The UAE Government publishes the data protection laws, and records covering gametes, embryos and genetic material need a lawful, secure handling and consent plan before the first patient is seen.

Decide early who owns the company, who operates the clinic, and who holds the facility licence covering the laboratory. These can be three different parties, particularly where an investment company owns the premises and a clinical operator runs the service; the health authority will want the licence holder and the responsible clinical and laboratory leadership named clearly.

Substance matters more here than in most sectors: the facility needs a real laboratory, real storage and named embryology and clinical leadership, and a licence with no laboratory behind it will not satisfy a health authority. Where investors sit above the clinical operator in a layered structure, plan a regulated and complex ownership setup before filing anything, so the licence holder and the ownership chain stay consistent from the first application.

Fertility treatment is paid for through several channels at once: self-pay patients, insurers that cover some or none of the treatment, and, in many clinics, patients who travel from outside the UAE. Each channel has its own settlement timing, and cross-border patient payments draw more scrutiny from a bank than a purely local patient base.

Storage fees add a channel most other clinics do not have: ongoing billing for gamete or embryo storage, often running for years after the procedure. A bank or acquirer will ask how storage revenue is billed and reconciled separately from procedure revenue.

Keep source of wealth and funds evidence ready for shareholders and lenders, and prepare the business plan and supporting documents so the procedure and patient-pathway map matches the ownership record and the application at every point. Treat corporate bank account readiness as its own workstream, run alongside the health-authority process rather than after it.

A related question is what kind of clinic is actually being opened. A multi-specialty clinic or day-surgery centre and an aesthetic medicine or dermatology clinic each raise different scope questions from a fertility centre, even where the premises look similar.

Laboratory fit-out, equipment, storage infrastructure and specialist recruitment typically outweigh the commercial registration cost, so sequence the build around the authority's facility and scope decision, not a lease date. In Dubai, a facility holding DHA's inactive licence can apply for professional licences, which activate automatically when the facility licence is activated. Renewals, inspections and tax filings continue after launch and belong in the plan from the outset.

Cost is built in layers, and the firm's fee is itemised in the engagement letter, as set out in how Velarozone works.